India is seeing a rise in pancreatic cancers, and a new drug may help.
Here are the latest news and analyses.1 / 20 Indian doctors test for pancreatic tumours, with one doctor finding cancer in the head and another finding tumours in the neckIndia is seeing an increase in pancreatin cancers, the first in the world.
The new study, published in The Lancet, found that doctors in New Delhi were using drugs to treat more pancreatic tumors than ever before.
The study found that in the last five years, there were 2,064 pancreatic tumor cases in the city, compared with 2,082 in the same period last year.
In New Delhi, the number of pancreatic cases jumped by 2,092 cases.
In the city of New Delhi alone, the study found, there are more than 1,500 pancreatic patients.
But the number is likely much higher.
“We have over 400,000 patients,” said Dr. S. N. Gautam, an Indian Medical Association (IMA) official.
“There are over 4,000 pancreatic-cancer patients.
It is an epidemic in India.”
The study also found that the number and type of pancreatitis – a condition in which a patient develops more than one pancreatic lesion – were increasing in India, and that the new drugs could be helpful in treating pancreatic problems.
“If we can get the new medicines, the rate of pancreato-liver cancer will also decrease,” said Pankaj Prakash, a leading pancreatic specialist in the state of Rajasthan.
Doctors are trying to find out why more cases are happening in India.
Dr. R. Sathyanarayana, director of the National Institute of Allergy and Infectious Diseases (NIAID), a public health agency in India’s capital, said the problem is related to a combination of factors.
“What we know is that we have a low vaccination rate, poor nutrition, lack of health awareness, and poverty, which makes people vulnerable,” he said.
The new drugs, called “viral vectors”, are being tested in India for the first time.
“These drugs are targeted for treatment of pancreatos, but the drugs themselves are not the problem,” said Prof. G. V. Venkatraman, the head of the NIAID’s division on immunization.
“But if we could get better nutrition, better health care and better access to medicines, it could be a major breakthrough,” he added.
Dr. Gopal Dasgupta, chief executive officer of NIAIDS, said in an interview with CNN that there is no vaccine for pancreatitis, and it’s the combination of the drugs that’s the problem.
“A vaccine is needed for pancreato, for liver and for pancreatos.
We don’t have the vaccines to address this.
It’s an epidemic,” he told CNN.
But a major reason for the rise in cases in India is a lack of awareness, Dr. Dasguptan said.
“Most people don’t know that pancreatitis is a disease.
They don’t even know that it’s an autoimmune disease.
So we have to educate them about it,” he explained.
India has one of the lowest rates of pancreatopreservation, a process where a pancreas is harvested from a patient’s body and implanted into the abdomen to treat the disease.
India has the lowest rate of treatment of any country in the developed world, with about two-thirds of pancreata transplants performed overseas.
India’s Ministry of Health has announced a new plan to increase pancreatic screenings for all Indians, including those with advanced pancreatic disease, cancer and autoimmune conditions.
However, the plan was delayed, and the Ministry of Social Justice and Empowerment has not announced a specific timeline for its rollout.
“India’s new National Pancreatic Disease Screening Plan, which will increase the number for screening and testing, has not yet been launched,” said the ministry in a statement.
The plan will also include more screening in hospitals, including in the outpatient clinics.
India’s National Pancreas Foundation has also launched a national pancreases awareness campaign.
Follow India Real Time on Twitter @indiarealtime.